Doxorubicin Induces Apoptosis through down Regulation of miR-21 Expression and Increases miR-21 Target Gene Expression in MCF-7 Breast Cancer Cells — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Doxorubicin Induces Apoptosis through down Regulation of miR-21 Expression and Increases miR-21 Target Gene Expression in MCF-7 Breast Cancer Cells
Department of Animal Biology, Tabriz University, Tabriz, Iran
,
Department of Biology, School of Basic Sciences, Science and Research Branch, Islamic Azad University (IAU), Tehran, Iran
,
Department of Biology, Kish International Campus, University of Tehran, Kish, Iran
,
Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
,
Department of Stem Cells and Developmental Biology at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
,
Department of Biology, Faculty of Advanced Sciences and Technology, Pharmaceutical Sciences Branch, Islamic Azad University (IAUPS), Tehran, Iran
,
Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
1 Department of Animal Biology, Tabriz University, Tabriz, Iran
2 Department of Biology, School of Basic Sciences, Science and Research Branch, Islamic Azad University (IAU), Tehran, Iran
3 Department of Biology, Kish International Campus, University of Tehran, Kish, Iran
4 Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
5 Department of Stem Cells and Developmental Biology at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
6 Department of Biology, Faculty of Advanced Sciences and Technology, Pharmaceutical Sciences Branch, Islamic Azad University (IAUPS), Tehran, Iran
7 Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
miRNAs play an important regulatory role in variety of cellular functions and several diseases, including cancer. MicroRNA-21 (miR-21) is overexpressed in almost all types of human cancers. Studies revealed that the knockdown of miR-21 results in reduced tumor cell growth, cell cycle arrest and cell apoptosis. In this study, we evaluated the effect of doxorubicin on miR-21 expression in mcf-7 breast cancer cells. miRNA was extracted from mcf-7 cells treated with doxorubicin and untreated cells using miRNeasy Kit (Qiagen) according to the manufacturer’s instructions. cDNA synthesis was performed using miScript II RT Kit (Qiagen) and Real Time-PCR was performed using Real Q Plus 2x Master Mix Green-(Ampliqon, Denmark). The relative expression of miR-16 and miR-21 was calculated using comparative Ct method. All tests were run in triplicate to minimize the experimental errors. Samples with a Ct > 37 were excluded from the analysis. Statistically, a significant decrease in cell proliferation of mcf-7 cells was found in doxorubicin group compared with control groups 24 hours after transfection, dose dependently (p value< 0.001). After 24 hours, Doxorubicin (100 μm) significantly decreased miR-21 expression in mcf-7 cells (p = 0.0001). Also, the expression of caspase 9 significantly increased after Doxorubicin (100 μm) treatment (p = 0.0003). Together, these findings indicate that miR-21 plays a key role in regulating cell apoptosis in mcf-7 cells and may serve as a target for effective therapies.
KeywordsmiR-21mcf-7 CellsCaspase 9Cancer
Sara, T., Mojtaba, S., Mahta, M., Parisa, N., Bahareh, N., Reza, S. and Nasrin, G. (2016) How Does the Cortactin Gene Expression Affect Breast Cancer among Iranian Females? Advances in Breast Cancer Research, 5, 142-149. https://doi.org/10.4236/abcr.2016.54017
Jalili, A., Roshandel, E., Shenasifam, S.H.F.N., Ebrahimi, A. and Sadrabadi, M.A.R.P. (2016) Appraising the Increased Expression of p21and p53 Genes in Paraffin-Embedded Biopsy Tissues of Patients with Bladder Cancer Exposed to Mitomycin C. Advances in Bioresearch, 7, 74-79.
Jalili, A., Sadrabadi, A.E. and Yekta, S.S. (2015) Assessing the Expression of BRAF Gene in Paraffin-Embedded Blocks of Patients with Colorectal Cancer. International Journal of Biology, Pharmacy and Allied Sciences, 4, 5653-5662.
Mohammadi, S., Mahboubi, A., Mohammadi, M., Hedayati, M. and Jalili, A. (2017) Assessing the Anticancer Effect of the Euphorbia Condylocarpa Plant on AGS Gastric Cancer Cell Line. Gene, Cell and Tissue, 4, e41223. https://doi.org/10.17795/gct-41223
Sadrabadi, A.E., Yekta, S.S., Fattahi, S.H., Molaei, S., Gavgani, S.P., Roshandel, E. and Jalili, A. (2015) Assessing the Decreased Expression of TP53 and P21 in Colorectal Cancer. Indian Journal of Fundamental and Applied Life Sciences, 5, 107-112.
Huang, X., Xiao, R., Pan, S., Yang, X., Yuan, W., Tu, Z., et al. (2017) Uncovering the Roles of Long Non-Coding RNAs in Cancer Stem Cells. Journal of hematology & oncology, 10, 62. https://doi.org/10.1186/s13045-017-0428-9
Elfandi, L., Said, G., Saleh, S.S., Marwan, M. and Enattah, N. (2016) Analysis of 6174delT Mutation in BRCA2 Gene by Mutagenically Separated PCR among Libyan Patients with Breast Cancer. Archives of Breast Cancer, 3, 8-13.
Lee, E. and Moon, A. (2016) Identification of Biomarkers for Breast Cancer Using Databases. Journal of Cancer Prevention, 21, 235-242. https://doi.org/10.15430/JCP.2016.21.4.235
Chatterjee, S.K. and Zetter, B.R. (2005) Cancer Biomarkers: Knowing the Present and Predicting the Future. Future Oncology, 1, 37-50. https://doi.org/10.1517/14796694.1.1.37
Tanic, M. and Beck, S. (2017) Epigenome-Wide Association Studies for Cancer Biomarker Discovery in Circulating Cell-Free DNA: Technical Advances and Challenges. Current Opinion in Genetics & Development, 42, 48-55. https://doi.org/10.1016/j.gde.2017.01.017
Wang, H., Shi, T., Qian, W.-J., Liu, T., Kagan, J., Srivastava, S., et al. (2016) The Clinical Impact of Recent Advances in LC-MS for Cancer Biomarker Discovery and Verification. Expert Review of Proteomics, 13, 99-114. https://doi.org/10.1586/14789450.2016.1122529
Li, Y., Deng, X., Zeng, X. and Peng, X. (2016) The Role of Mir-148a in Cancer. Journal of Cancer, 7, 1233-1241. https://doi.org/10.7150/jca.14616
Denzler, R., McGeary, S.E., Title, A.C., Agarwal, V., Bartel, D.P. and Stoffel, M. (2016) Impact of MicroRNA Levels, Target-Site Complementarity, and Cooperativity on Competing Endogenous RNA-Regulated Gene Expression. Molecular Cell, 64, 565-579. https://doi.org/10.1016/j.molcel.2016.09.027
Dykxhoorn, D.M. (2010) MicroRNAs and Metastasis: Little RNAs Go a Long Way. Cancer Research, 70, 6401-6406. https://doi.org/10.1158/0008-5472.CAN-10-1346
Jafri, M.A., Al-Qahtani, M.H. and Shay, J.W., Eds. (2017) Role of miRNAs in Human Cancer Metastasis: Implications for Therapeutic Intervention. Seminars in Cancer Biology, in press.
Livingstone, M.C., Johnson, N.M., Roebuck, B.D., Kensler, T.W. and Groopman, J.D. (2017) Profound Changes in miRNA Expression during Cancer Initiation by Aflatoxin B1 and Their Abrogation by the Chemopreventive Triterpenoid CDDO-Im. Molecular Carcinogenesis, in press. https://doi.org/10.1002/mc.22635
Singh, S., Sharma, P.K., Kumar, N. and Dudhe, R. (2011) A Review on a Versatile Molecule: Chalcone. Asian J Pharm Biol Res, 412-418.
Klinge, C.M. (2015) miRNAs Regulated by Estrogens, Tamoxifen, and Endocrine Disruptors and Their Downstream Gene Targets. Molecular and Cellular Endocrinology, 418, 273-297. https://doi.org/10.1016/j.mce.2015.01.035
Wang, S., Wan, X. and Ruan, Q. (2016) The MicroRNA-21 in Autoimmune Diseases. International Journal of Molecular Sciences, 17, 864. https://doi.org/10.3390/ijms17060864
Volinia, S., Galasso, M., Costinean, S., Tagliavini, L., Gamberoni, G., Drusco, A., et al. (2010) Reprogramming of miRNA Networks in Cancer and Leukemia. Genome Research, 20, 589-599. https://doi.org/10.1101/gr.098046.109
Croce, C.M. (2011) miRNAs in the Spotlight: Understanding Cancer Gene Dependency. Nature Medicine, 17, 935-936. https://doi.org/10.1038/nm0811-935
Papagiannakopoulos, T., Shapiro, A. and Kosik, K.S. (2008) MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells. Cancer Research, 68, 8164-8172. https://doi.org/10.1158/0008-5472.CAN-08-1305
Park, J.-K., Lee, E.J., Esau, C. and Schmittgen, T.D. (2009) Antisense Inhibition of microRNA-21 or-221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma. Pancreas, 38, e190-e199. https://doi.org/10.1097/MPA.0b013e3181ba82e1
Tomuleasa, C.I., Foris, V., Soritau, O., Pall, E., Fischer-Fodor, E., Lung-Illes, V., et al. (2009) Effects of 60Co Gamma-Rays on Human Osteoprogenitor Cells. Romanian Journal of Morphology and Embryology, 50, 349-355.
Cramer, H., Lauche, R., Klose, P., Lange, S., Langhorst, J. and Dobos, G.J. (2017) Yoga for Improving Health-Related Quality of Life, Mental Health and Cancer-Related Symptoms in Women Diagnosed with Breast Cancer. The Cochrane Database of Systematic Reviews, No. 1, CD010802. https://doi.org/10.1002/14651858.cd010802.pub2
Lobo, M.D., Moreno, F.B., Souza, G.H., Verde, S.M., Moreira, R.A. and Monteiro-Moreira, A.C. (2017) Label-Free Proteome Analysis of Plasma from Patients with Breast Cancer: Stage-Specific Protein Expression. Frontiers in Oncology, 7, 14. https://doi.org/10.3389/fonc.2017.00014
Owen, L.N. (1979) A Comparative Study of Canine and Human Breast Cancer. Investigative & Cell Pathology, 2, 257-275.
Arslan, C., Dizdar, O. and Altundag, K. (2014) Chemotherapy and Biological Treatment Options in Breast Cancer Patients with Brain Metastasis: An Update. Expert Opinion on Pharmacotherapy, 15, 1643-1658. https://doi.org/10.1517/14656566.2014.929664
Jolly, T.A., Williams, G.R., Bushan, S., Pergolotti, M., Nyrop, K.A., Jones, E.L., et al. (2016) Adjuvant Treatment for Older Women with Invasive Breast Cancer. Women’s Health (London, England), 12, 129-145; quiz 45-46.
Pal, A. and Donato, N.J. (2014) Ubiquitin-Specific Proteases as Therapeutic Targets for the Treatment of Breast Cancer. Breast Cancer Research, 16, 461. https://doi.org/10.1186/s13058-014-0461-3
Casalini, P. and Iorio, M.V. (2009) MicroRNAs and Future Therapeutic Applications in Cancer. Journal of BUON, 14, S17-S22.
Johnson, S.M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., et al. (2005) RAS Is Regulated by the let-7 microRNA Family. Cell, 120, 635-647. https://doi.org/10.1016/j.cell.2005.01.014
Croce, C.M. (2009) Causes and Consequences of microRNA Dysregulation in Cancer. Nature Reviews Genetics, 10, 704-714. https://doi.org/10.1038/nrg2634
Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., et al. (2006) A microRNA Expression Signature of Human Solid Tumors Defines Cancer Gene Targets. Proceedings of the National Academy of Sciences of the United States of America, 103, 2257-2261. https://doi.org/10.1073/pnas.0510565103
Hwang, J.H., Voortman, J., Giovannetti, E., Steinberg, S.M., Leon, L.G., Kim, Y.T., et al. (2010) Identification of microRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer. PLoS ONE, 5, e10630. https://doi.org/10.1371/journal.pone.0010630
Yan, L.-X., Huang, X.-F., Shao, Q., Huang, M.A.Y., Deng, L., Wu, Q.-L., et al. (2008) MicroRNA miR-21 Overex-pression in Human Breast Cancer Is Associated with Advanced Clinical Stage, Lymph Node Metastasis and Patient Poor Prognosis. RNA, 14, 2348-2360. https://doi.org/10.1261/rna.1034808
Buscaglia, L.E.B. and Li, Y. (2011) Apoptosis and the Target Genes of microRNA-21. Chinese Journal of Cancer, 30, 371-380. https://doi.org/10.5732/cjc.30.0371
Yan, L.X., Wu, Q.N., Zhang, Y., Li, Y.Y., Liao, D.Z., Hou, J.H., et al. (2011) Knockdown of miR-21 in Human Breast Cancer Cell Lines Inhibits Proliferation, in Vitro Migration and in Vivo Tumor Growth. Breast Cancer Research, 13, R2.